Drug safety is a very relevant issue when dealing with patients with chronic kidney disease (CKD) who need vascular access procedures and interventions. Drug dosage adjustments are needed for patients with acute or chronic kidney disease. In CKD patients, the estimated glomerular filtration rate is used to guide dose adjustments. Determining the influence of renal replacement therapies on drug dosage adjustment is also very important. Safety issues for the following drugs used for situations related to vascular access are reported: anticoagulants and antiplatelet agents, antibiotics, antimicrobials for catheter lock therapy, thrombolytics, local anesthetics, and painkillers. General principles of the interactions of drugs in CKD are also reported.

What every doctor should know about drug safety in patients with chronic kidney disease / M. Paparella, V. Martina, M.A. Rizzo, M. Gallieni. - In: CONTRIBUTIONS TO NEPHROLOGY. - ISSN 0302-5144. - 184(2015), pp. 24-50.

What every doctor should know about drug safety in patients with chronic kidney disease

M. Gallieni
Ultimo
2015

Abstract

Drug safety is a very relevant issue when dealing with patients with chronic kidney disease (CKD) who need vascular access procedures and interventions. Drug dosage adjustments are needed for patients with acute or chronic kidney disease. In CKD patients, the estimated glomerular filtration rate is used to guide dose adjustments. Determining the influence of renal replacement therapies on drug dosage adjustment is also very important. Safety issues for the following drugs used for situations related to vascular access are reported: anticoagulants and antiplatelet agents, antibiotics, antimicrobials for catheter lock therapy, thrombolytics, local anesthetics, and painkillers. General principles of the interactions of drugs in CKD are also reported.
Drug safety; Chronic kidney disease; Drug interactions; Glomerular filtration rate; Renal failure; Dialysis; Hemodialysis; Vascular Access; Infection; Thrombosis
Settore MED/14 - Nefrologia
2015
Article (author)
File in questo prodotto:
File Dimensione Formato  
Gallieni - Contribution to Nephrology 2014 - Patient safety - Chapter drug safety - with figures.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 857.95 kB
Formato Adobe PDF
857.95 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/265349
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact